Inhibition of Human Eosinophil Chemotaxis in Vitro by the Anti-Allergic Agent Emedastine Difumarate
- 1 January 1996
- journal article
- research article
- Published by Taylor & Francis in Immunopharmacology and Immunotoxicology
- Vol. 18 (4) , 587-595
- https://doi.org/10.3109/08923979609052755
Abstract
Emedastine difumarate (emedastine), an anti-allergic agent with anti-histaminic properties, was studied for its effect on human eosinophil chemotaxis induced by platelet activating factor (PAF). Peripheral blood eosinophils (98% purity) were obtained from healthy donors and chemotaxis assay were performed in microchemotaxis chambers. Emedastine showed a significant inhibitory effect on 10−6 M PAF-induced eosinophil chemotaxis, in dose dependent fashion, at concentrations from 10−6 to 10−8 M. Conversely, no inhibitory effect was observed on human neutrophil chemotaxis. Pretreatment of eosinophils with Pyrilamine did not affect PAF-induced eosinophil chemotaxis. Thus emedastine appears to possess a potent and selective inhibitory effect on eosinophils chemotaxis, an action which is probably unrelated to its anti-histamine properties.Keywords
This publication has 14 references indexed in Scilit:
- Purification of human blood eosinophils by negative selection using immunomagnetic beadsJournal of Immunological Methods, 1989
- Heterogeneity of human eosinophilsJournal of Allergy and Clinical Immunology, 1989
- The eosinophil as a mediator of damage to respiratory epithelium: A model for bronchial hyperreactivityJournal of Allergy and Clinical Immunology, 1988
- Pharmacologic analysis of LY188695 (KB-2413), 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimidazole difumarate, a potent histamine1 receptor antagonistInflammation Research, 1987
- Inhibition of Chemical Mediator Release from Human Leukocytes and Lung in Vitro by A Novel Antiallergic Agent, Kb-2413Immunopharmacology and Immunotoxicology, 1987
- Eosinophil Activation in Allergic DiseaseInternational Archives of Allergy and Immunology, 1987
- Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.Journal of Clinical Investigation, 1986
- Platelet-Activating Factor (PAF-Acether) Secretion from Platelets: Effect of Aggregating AgentsBritish Journal of Haematology, 1980
- Platelet‐activating factor and macrophages. I. Evidence for the release from rat and mouse peritoneal macrophages and not from mastocytesEuropean Journal of Immunology, 1979
- LEUKOCYTE-DEPENDENT HISTAMINE RELEASE FROM RABBIT PLATELETSThe Journal of Experimental Medicine, 1972